Literature DB >> 6717609

Dopaminergic binding sites in rat striatal slices and the action of guanyl nucleotides.

M P Martres, P Sokoloff, J C Schwartz.   

Abstract

Dopaminergic binding sites were studied in slices from rat striatum incubated in a physiological medium and using the two highly selective ligands 3H-apomorphine and 3H-domperidone. The clearly biphasic or stretched inhibition of the specific binding of these two ligands by domperidone or apomorphine, respectively allowed to define three distinct classes of binding site. It was demonstrated, by comparing the binding of the 3H-ligand added at the beginning of slice incubation or just before homogenisation of tissue and filtration, that the "specific" bindings only occurred during the incubation of slices. The inhibition constants (Ki values) of dopaminergic agents for the three classes of binding site as also the dissociation constants (Kd values) of 3H-ligands and the maximal capacity (Bmax) of the three classes of binding site were closely similar to those of binding sites previously demonstrated on rat striatal membranes, namely D-2, D-3 and D-4 sites (Sokoloff et al. 1980 a, b). Their identification on a preparation in which the cellular organisation is largely preserved rules out the possibility that these sites represent an artifact due to membrane preparation. Unexpectedly the addition of guanyl nucleotides like GTP or GppNHp to the slice preparation decreased the binding of 3H-apomorphine to the high affinity sites (particularly to the D-2 sites) while D-4 site binding was correspondingly increased. The guanyl nucleotide effect apparently took place before cell disruption and occurred at concentrations similar to those required in striatal membrane preparations. These observations, together with those indicating the presence of high affinity binding sites for dopaminergic agonists in intact striatal cells, suggest that a putative nucleotide regulatory unit of dopamine receptors, is not fully occupied by intracellular GTP but could be interacted with from the external face of the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6717609     DOI: 10.1007/bf00506190

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  26 in total

1.  Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs.

Authors:  P M Laduron; P F Janssen; J E Leysen
Journal:  Biochem Pharmacol       Date:  1978-02-01       Impact factor: 5.858

2.  In vivo binding of 3H-pimozide in mouse striatum: effects of dopamine agonists and antagonists.

Authors:  M Baudry; M P Martres; J C Schwartz
Journal:  Life Sci       Date:  1977-10-15       Impact factor: 5.037

3.  Guanine nucleotides distinguish between two dopamine receptors.

Authors:  I Creese; T Usdin; S H Snyder
Journal:  Nature       Date:  1979-04-05       Impact factor: 49.962

4.  [3H]Quinuclidinyl benzilate binding to muscarinic receptors and [3H]WB-4101 binding to alpha-adrenergic receptors in rabbit iris. Comparison of results in slices and microsomal fractions.

Authors:  W C Taft; A A Abdel-Latif; R A Akhtar
Journal:  Biochem Pharmacol       Date:  1980-10-15       Impact factor: 5.858

5.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

6.  Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.

Authors:  C Köhler; S O Ogren; L Haglund; T Angeby
Journal:  Neurosci Lett       Date:  1979-06       Impact factor: 3.046

7.  3H-Domperidone: a selective ligand for dopamine receptors.

Authors:  M Baudry; M P Martres; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-09       Impact factor: 3.000

8.  Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors.

Authors:  C Köhler; K Fuxe; S B Ross
Journal:  Eur J Pharmacol       Date:  1981-07-10       Impact factor: 4.432

9.  Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations.

Authors:  S B Freedman; J A Poat; G N Woodruff
Journal:  J Neurochem       Date:  1981-09       Impact factor: 5.372

10.  Heat treatment mimics guanosine-5'-triphosphate effects on dopaminergic 3H-ligand binding to bovine caudate membranes.

Authors:  M W Hamblin; I Creese
Journal:  Mol Pharmacol       Date:  1982-01       Impact factor: 4.436

View more
  2 in total

1.  Autoradiographic localisation of 3H-apomorphine binding sites in rat brain.

Authors:  M L Bouthenet; N Sales; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-07       Impact factor: 3.000

2.  Effects of discriminant and non-discriminant dopamine antagonists on in vivo accumulation of 3H-N-propyl-norapomorphine in mouse striatum and tuberculum olfactorium.

Authors:  C Gulat-Marnay; A Lafitte; J C Schwartz; P Protais
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.